+ All Categories
Home > Documents > Slackers Guide to Hematologic Cancers

Slackers Guide to Hematologic Cancers

Date post: 22-Mar-2016
Category:
Upload: colum
View: 28 times
Download: 0 times
Share this document with a friend
Description:
Slackers Guide to Hematologic Cancers. Mike Ori. Disclaimer. These represent my understanding of the subject and have not been vetted or reviewed by faculty. Use at your own peril. I can’t type so below are common missing letters you may need to supply e r l - PowerPoint PPT Presentation
214
Slackers Guide to Hematologic Cancers Mike Ori
Transcript
Page 1: Slackers Guide  to Hematologic Cancers

Slackers Guide to Hematologic Cancers

Mike Ori

Page 2: Slackers Guide  to Hematologic Cancers

Disclaimer

• These represent my understanding of the subject and have not been vetted or reviewed by faculty. Use at your own peril.

• I can’t type so below are common missing letters you may need to supply

• e r l• I didn’t use greek letters because they are a pain

to cut and paste in.

Page 3: Slackers Guide  to Hematologic Cancers

• What are the six hallmarks of cancer

Page 4: Slackers Guide  to Hematologic Cancers

• Evasion of apoptosis• Insensitivity to anti-growth signals• Self sufficiency of growth signals• Limitless replication potential• Sustained Angiogenesis• Tissue invasion and metastasis

Page 5: Slackers Guide  to Hematologic Cancers

• What is the Warburg effect

Page 6: Slackers Guide  to Hematologic Cancers

• It is the observation that cancer cells rely more heavily on glycolysis than on oxidative phosphorylation even in the presence of adequate oxygen supplies. Thus it is believed that the glycolysis is better suited to meet the metabolic demands of cancer cells.

Page 7: Slackers Guide  to Hematologic Cancers

• What is epigenetics • List a few epigenetic mechanisms in the cell

Page 8: Slackers Guide  to Hematologic Cancers

• Epigenetics refers to reversible but inheritable changes in gene expression that occur without mutations. Examples include– Methylation– Histone acetylation

• Both examples limit the access of promoter regions to their respective promoters.

Page 9: Slackers Guide  to Hematologic Cancers

• What is the function of micro RNA

Page 10: Slackers Guide  to Hematologic Cancers

• miRNA are small (~22bp) RNA strands that function at the post transcriptional level to silence specific genes. Each miRNA may interact with multiple genes and thus can serve as an off switch post transcriptionally.

• Some oncogenes control the expression of miRNA.

Page 11: Slackers Guide  to Hematologic Cancers

• What is mismatch repair?

Page 12: Slackers Guide  to Hematologic Cancers

• DNA replications “spell checker”. It makes sure A-T and G-C go together.

Page 13: Slackers Guide  to Hematologic Cancers

• What is Nucleotide excision repair

Page 14: Slackers Guide  to Hematologic Cancers

• Removal of pyrimidine dimers caused by UV radiation

Page 15: Slackers Guide  to Hematologic Cancers

• What is the function of p53

Page 16: Slackers Guide  to Hematologic Cancers

• P53 is a tumor suppressor gene.• It activates DNA repair genes• It can arrest the cell cycle at G1/S checkpoint• It can initiate apoptosis

Page 17: Slackers Guide  to Hematologic Cancers

• What is the function of ATM

Page 18: Slackers Guide  to Hematologic Cancers

• ATM is a tumor suppressor protein

Page 19: Slackers Guide  to Hematologic Cancers

• What is the function of Her2/neu/erb-b2

Page 20: Slackers Guide  to Hematologic Cancers

• An epithelial growth factor receptor whose gene is amplified in 25% of breast cancers.

• Self-sufficiency in growth signals

Page 21: Slackers Guide  to Hematologic Cancers

• What drug targets her2 and what is its mechanism

Page 22: Slackers Guide  to Hematologic Cancers

• Trastuzumab is a monoclonal antibody directed against her2/neu/Erb b2.

• It functions by binding to and disrupting erb b2

Page 23: Slackers Guide  to Hematologic Cancers

• What is BCR-ABL and how does it result in cancer

Page 24: Slackers Guide  to Hematologic Cancers

• BCR-ABL is a unique protein that from t(9:22) translocation that results in the fusion of the BCR promoter to the ABL tyrosine kinase in such a way that the kinase no longer requires a ligand for activation.

• ABL is a proliferative kinase that is active in hematopoietic cells

Page 25: Slackers Guide  to Hematologic Cancers

• Describe the role of B-catenin and APC in cancer

Page 26: Slackers Guide  to Hematologic Cancers

• B-catenin is a cell proliferation enzyme that is sequestered by APC.

• The deletion of one APC allele causes familial adenomatous polyposis, an autosomal dominant condition that predisposes to colon cancer in early adulthood

• Mutations in APC can lead to attenuated colon cancer forms

Page 27: Slackers Guide  to Hematologic Cancers

• What are the three benign types of lymphadenopathy

Page 28: Slackers Guide  to Hematologic Cancers

• Follicular– Expansion of B cells

• Paracortical– Expansion of T cells

• Sinus histiocytes– Surgical drainage

Page 29: Slackers Guide  to Hematologic Cancers

• What is the common gene involved with lymphoma translocation

Page 30: Slackers Guide  to Hematologic Cancers

• The heavy chain gene on CR14

Page 31: Slackers Guide  to Hematologic Cancers

• Why are immune cells susceptible to translocations?

Page 32: Slackers Guide  to Hematologic Cancers

• DNA cleavage is an important part of maturation of immune cells. This presents opportunity for abnormal joining.

Page 33: Slackers Guide  to Hematologic Cancers

• What is the etiologic classifications of lymphoma

Page 34: Slackers Guide  to Hematologic Cancers

• Translocations• Inherited– Downs, neurofibromatosis

• Viruses– HTLV, EBV, HHV-8

• Environmental agents• Iatrogenic– Radiation

Page 35: Slackers Guide  to Hematologic Cancers

• Describe the relationship of lymphoma and leukemia

Page 36: Slackers Guide  to Hematologic Cancers

• Lymphocytic leukemias evolve to lymphomas late. Similarly, lymphomas may transform into lymphocytic leukemias.

Page 37: Slackers Guide  to Hematologic Cancers

• Describe follicular lymphoma

Page 38: Slackers Guide  to Hematologic Cancers

• Common indolent lyphoma• Back to back follicles• T(14:18) BCL-2– Anti-apoptotic

• May transform into diffuse large cell lymphoma

Page 39: Slackers Guide  to Hematologic Cancers

• Describe diffuse large cell lymphoma

Page 40: Slackers Guide  to Hematologic Cancers

• Large round lymphocytes• Alterations in BCL-6– Germinal center formation disrupted

Page 41: Slackers Guide  to Hematologic Cancers

• Describe Burkitts Lymphoma

Page 42: Slackers Guide  to Hematologic Cancers

• Rapidly aggressive lymphoma• T(8:14) c-myc oncogene• Association with EBV• Starry sky pattern due to histiocytes

Page 43: Slackers Guide  to Hematologic Cancers

• Describe marginal zone lymphomas

Page 44: Slackers Guide  to Hematologic Cancers

• Associated with MALT in gut• Chronically inflamed tissue– H. pylori

• Indolent but may transform to diffuse B-cell

Page 45: Slackers Guide  to Hematologic Cancers

• Describe hodgkins lymphoma

Page 46: Slackers Guide  to Hematologic Cancers

• Common cancer of young adults• Orderly progression from local nodes to

spleen to liver to bone marrow• Reed-sternberg cells

Page 47: Slackers Guide  to Hematologic Cancers

• Describe Mycosis Fungoides

Page 48: Slackers Guide  to Hematologic Cancers

• T cell lymphoma– CD4+– Band like infiltrates in dermis

• Flat erythematous rash -> plaques -> tumor nodules• TX with local control early• Sezary syndrome– Widespread rash– Blood and lymph node involvement– Poor prognosis

Page 49: Slackers Guide  to Hematologic Cancers

• List the myeloid cells

Page 50: Slackers Guide  to Hematologic Cancers

• Granulocytes– Neutrophils– Eosinophils– Basophils

• Monocytes• Erythrocytes• Megakaryocytes

Page 51: Slackers Guide  to Hematologic Cancers

• Differentiate myeloproliferative neoplasms, myelodysplastic syndromes, and myelogenous leukemias

Page 52: Slackers Guide  to Hematologic Cancers

• MPN– Clonal proliferation of a myeloid precursor – Retains ability to mature– Effective hematopoiesis– Expansion of one or more related cell lines– Normal blast levels

• MDS– Clonal proliferation of myeloid precursors– Retains ability to mature– Ineffective hematopoiesis– Peripheral cytopenia– Elevated blasts account for < 20% of marrow

• Leukemia– Malignant neoplasms of the hematopoietic precursors– Blasts account for more than 20% of the marrow– Classified as acute or chronic depending on maturity of cells

Page 53: Slackers Guide  to Hematologic Cancers

• Describe the blood counts of leukemic patients

Page 54: Slackers Guide  to Hematologic Cancers

• In some instances there may be elevated counts and in some instances cytopenia may result.

Page 55: Slackers Guide  to Hematologic Cancers

• If a sample shows clonal origin, what does this imply?

Page 56: Slackers Guide  to Hematologic Cancers

• This strongly implies a dysplastic/neoplastic process. Excess growth hormones would affect all members of a lineage sensitive to the hormone.

Page 57: Slackers Guide  to Hematologic Cancers

• Why is BCR-ABL a favorable indicator in CML but not in AML

Page 58: Slackers Guide  to Hematologic Cancers

• The fusion products are similar but are not the same.

Page 59: Slackers Guide  to Hematologic Cancers

• Are auer rods present in ALL

Page 60: Slackers Guide  to Hematologic Cancers

• No. Auer rods are an AML finding.

Page 61: Slackers Guide  to Hematologic Cancers

• What are the two categories of acute lymphoblastic leukemia

Page 62: Slackers Guide  to Hematologic Cancers

• B cell• T cell

Page 63: Slackers Guide  to Hematologic Cancers

• What are the classic populations for ALL

Page 64: Slackers Guide  to Hematologic Cancers

• B cell – children• T cell – adolescent males as lymphoma

Page 65: Slackers Guide  to Hematologic Cancers

• What are the prognostic indicators for ALL

Page 66: Slackers Guide  to Hematologic Cancers

Favorable Unfavorable

Hyperdiploidy hypodiploidy

1-10 yo <1 or > 10 yo

WBC < 50x109 /L WBC > 50x109 /L

TEL-AML1 MLL, BCR-ABL, E2A-PBX1

Trisomy 4,10, or 17

Induction failure

CNS disease

Page 67: Slackers Guide  to Hematologic Cancers

• Describe the treatment terms for leukemia

Page 68: Slackers Guide  to Hematologic Cancers

• Induction– Therapy intended to reduce cancer cells to below

cytologic detection levels• Consolidation– Therapy intended to further reduce tumor cells

• Continuation– Maintenance therapy intended to insure

continued remission

Page 69: Slackers Guide  to Hematologic Cancers

• When would a stem cell transplant be considered in ALL

Page 70: Slackers Guide  to Hematologic Cancers

• 1st remission if poor prognostic factors• 2nd remission if < 1 year

Page 71: Slackers Guide  to Hematologic Cancers

• What is the cell of origin for chronic lymphocytic leukemia?

Page 72: Slackers Guide  to Hematologic Cancers

• 95% are B-cell• 5% are T cell

Page 73: Slackers Guide  to Hematologic Cancers

• What is the initial treatment for CLL

Page 74: Slackers Guide  to Hematologic Cancers

• Watchful waiting• 10% yearly transform to diffuse B-cell

Page 75: Slackers Guide  to Hematologic Cancers

• When would it be prudent to institute TX in CLL?

Page 76: Slackers Guide  to Hematologic Cancers

• Conversion to prolymphocytic or diffuse B cell lymphoma

• Worsening B symptoms• Progressive adenopathy or hepatosplenomegaly• Peripheral blood cytopenias• Recurring infections• Immune mediated complications such as hemolytic

anemia• Short doubling time of peripheral lymphocyte count

Page 77: Slackers Guide  to Hematologic Cancers

• List the myeloproliferative disorders

Page 78: Slackers Guide  to Hematologic Cancers

• Chronic Myelogenous Leukemia• Polycythemia Rubra Vera• Essential thrombocytosis• Primary myelofibrosis

Page 79: Slackers Guide  to Hematologic Cancers

• List several attractions of CML’s favorite city

Page 80: Slackers Guide  to Hematologic Cancers

• Philadelphia– Cheese steaks– Liberty bell– Independence hall– Eagles– http://www.phillyfunguide.com for more…who

knew ( I just realized knew is a funny word)

Page 81: Slackers Guide  to Hematologic Cancers

• What are the common clinical and lab findings in CML?

Page 82: Slackers Guide  to Hematologic Cancers

• WBC – count > 50k/ul– All forms increases

• RBC– Decreased

• Thrombocytosis• Splenomegaly

Page 83: Slackers Guide  to Hematologic Cancers

• What is the common genetic pathway altered in other myeloproliferative disorders

Page 84: Slackers Guide  to Hematologic Cancers

• JAK2

Page 85: Slackers Guide  to Hematologic Cancers

• Describe polycythemia vera

Page 86: Slackers Guide  to Hematologic Cancers

• Absolute increase in RBC’s but other lines may also be affected

• Platelets often 500,000/ul• Issues related to blood viscosity

Page 87: Slackers Guide  to Hematologic Cancers

• What is the most likely outcome of increased blood viscosity

Page 88: Slackers Guide  to Hematologic Cancers

• Thrombosis

Page 89: Slackers Guide  to Hematologic Cancers

• What is the treatment course for PV

Page 90: Slackers Guide  to Hematologic Cancers

• Watchful waiting• Blood letting– phlebotomy– Leeches– Cage matches • 16 references were cited on the Blood Letting wikipedia

page vs 93 references on the Professional Wrestling Match types page so I guess cage matches have more evidence. No chochrane reviews though.

Page 91: Slackers Guide  to Hematologic Cancers

• Describe essential thrombocytosis

Page 92: Slackers Guide  to Hematologic Cancers

• ET is an increase in thrombocytes that cannot be explained by any other cause

• Megakaryocytes have decreased need to growth factors and thus are increased in the marrow

• Platelet function may be poor.

Page 93: Slackers Guide  to Hematologic Cancers

• What is the primary risk with ET

Page 94: Slackers Guide  to Hematologic Cancers

• Abduction and probing

• Really, if you didn’t know it was thrombotic events, you are a slacker.

Page 95: Slackers Guide  to Hematologic Cancers

• Describe myelofibrosis

Page 96: Slackers Guide  to Hematologic Cancers

• Fibrous marrow • Primary– If no other reason established

• Secondary– Arises due to “burned out” marrow from CML or

PV• Extramedullary hematopoieis – Massive splenomegaly

Page 97: Slackers Guide  to Hematologic Cancers

• What drug is useful in decreasing WBC count in CML

Page 98: Slackers Guide  to Hematologic Cancers

• Hydroxyurea

Page 99: Slackers Guide  to Hematologic Cancers

• What is the most common pediatric leukemia and what is its survival rate

Page 100: Slackers Guide  to Hematologic Cancers

• ALL• 80% survival

Page 101: Slackers Guide  to Hematologic Cancers

• List the genetic changes in lymphoma

Page 102: Slackers Guide  to Hematologic Cancers

ALL TEL-AML1 T(12;21) AML converts from a transcription activator to a repressor. Only good indicator.

ALL BCR-ABL T(9;22) Constitutively active tyrosine kinase

ALL MLL HOX gene promoter

ALL E2A-PBX1 T(1;19) HOX gene regulator

Burkits Myc T(8;14) Myc oncogene

Page 103: Slackers Guide  to Hematologic Cancers

• What is the typical age of presentation for hodgkins vs non-hodgkins lymphoma

Page 104: Slackers Guide  to Hematologic Cancers

• Hodgkins = late 20’s• NHL = 60’s

Page 105: Slackers Guide  to Hematologic Cancers

• List the major risk factors for lymphoma

Page 106: Slackers Guide  to Hematologic Cancers

• Immunodeficiency– Acquired

• HIV, organ transplant– Inherited

• Autoimmune disease– RA, SLE, Sjogrens, Celiac

• Infection– Viruses

• HIV, EBV, HTLV, HEP C, HHV 8– Bacteria

• H pylori

Page 107: Slackers Guide  to Hematologic Cancers

• What are the B symptoms

Page 108: Slackers Guide  to Hematologic Cancers

• Drenching night sweats• FUO• Unexplained weight loss > 10%

Page 109: Slackers Guide  to Hematologic Cancers

• Describe the biopsy technique for suspected lymphoma

Page 110: Slackers Guide  to Hematologic Cancers

• Preferable is excisional biopsy of the suspected node. Otherwise need a core needle biopsy. Fine needle is insufficient

Page 111: Slackers Guide  to Hematologic Cancers

• List the Ann Arbor criteria for staging lymphomas

Page 112: Slackers Guide  to Hematologic Cancers

Stage

I Single lymph node region

II Multiple lymph node regions on same side of diaphragm

III Multiple lymph node regions across diaphragm

IV Extralymphatic non-contiguous involvement

SuffixB B sx present

A No B sx

E Extralymphatic

X Bulky

S Splenic

Page 113: Slackers Guide  to Hematologic Cancers

• What are the prognostic factors for lymphoma

Page 114: Slackers Guide  to Hematologic Cancers

• APLES• Age > 60• Performance status > 1• LDH > normal• Extra nodal sites > 1• Stage III/IV

Page 115: Slackers Guide  to Hematologic Cancers

• What are the risk factors for Non-hodkgins lymphoma

Page 116: Slackers Guide  to Hematologic Cancers

• WALSHAM• WBC > 15K• Albumin < 4 g/dl• Lymphocyte count < 600/ul• Stage IV• Hemoglobin < 10.5 g/dl• Age > 45• Male

Page 117: Slackers Guide  to Hematologic Cancers

• List the indolent, aggressive, and highly aggressive lymphomas

Page 118: Slackers Guide  to Hematologic Cancers

• Indolent– Follicular– Small lymphocytic– Marginal zone

• Aggressive– Diffuse large B-cell– Mantle cell

• Highly aggressive– Burkitts– Precursor B/T cell

Page 119: Slackers Guide  to Hematologic Cancers

• What is the treatment for indolent lymphoma

Page 120: Slackers Guide  to Hematologic Cancers

• Watchful waiting until– cytopenia– Leukemia– Marked splenomegaly, pelural effusion,

compressive symptoms– Single large node > 7cm– 3 nodes > 3cm

Page 121: Slackers Guide  to Hematologic Cancers

• What is the treatment for aggressive lymphoma

Page 122: Slackers Guide  to Hematologic Cancers

• R-CHOP• Rituximab• Cyclophosphamide• Doxorubacin• Vincristine• Prednisone

Page 123: Slackers Guide  to Hematologic Cancers

• What is the treatment regemin for non-hodgkin’s lymphoma

Page 124: Slackers Guide  to Hematologic Cancers

• ABVD• Doxorubicin• Bleomycin• Vinblastine• dacarbazine

Page 125: Slackers Guide  to Hematologic Cancers

• What is the signature side effect for doxorubicin

Page 126: Slackers Guide  to Hematologic Cancers

• CHF/cardiac toxicity• AML

Page 127: Slackers Guide  to Hematologic Cancers

• What is the principle side effect of vincristine

Page 128: Slackers Guide  to Hematologic Cancers

• Peripheral neuropathy• Constipation

Page 129: Slackers Guide  to Hematologic Cancers

• What is the principle side effect of bleomycin

Page 130: Slackers Guide  to Hematologic Cancers

• Pulmonary fibrosis

Page 131: Slackers Guide  to Hematologic Cancers

• Describe autologous stem cell transplant

Page 132: Slackers Guide  to Hematologic Cancers

• Autologous– From self– Risk of recurrence due to contamination or

continued gene defects– No graft v leukemia reaction– No graft v host reaction

Page 133: Slackers Guide  to Hematologic Cancers

• Describe syngenic stem cell transplant

Page 134: Slackers Guide  to Hematologic Cancers

• Syngenic– From an identical twin– No contamination with disease cells– Genetic defects remain– No graft v leukemia reaction– No graft v host reaction

Page 135: Slackers Guide  to Hematologic Cancers

• Describe allogenic stem cell transplant

Page 136: Slackers Guide  to Hematologic Cancers

• Allogenic– From another member of the species that is not

identical– No contamination with disease cells– Should not have similar genetic defects– Graft v leukemia reaction– Graft v host reaction

Page 137: Slackers Guide  to Hematologic Cancers

• What are the sources for stem cells

Page 138: Slackers Guide  to Hematologic Cancers

• Bone marrow aspirate• Cord blood• Peripheral blood– G-CSF– AMD3100 – allows stem cells to leave marrow

Page 139: Slackers Guide  to Hematologic Cancers

• When should SCT be considered

Page 140: Slackers Guide  to Hematologic Cancers

ALL

AML Allogenic 1st remission high risk, 2nd otherwise

CLL Allogenic or autologous

CML Allogenic After imatinib failure

NHL

Hodgkins Autologous

Myelodysplastic Syndroms

Allogenic If < 40yo and high risk

Multiple myeloma

Autotransplant

Most common reason for autotransplant

Page 141: Slackers Guide  to Hematologic Cancers

• What are the risk factors for prostate adenocarcinoma

Page 142: Slackers Guide  to Hematologic Cancers

• Age• Race• Family history• Diet• Cadmium exposure• Vasectomy (controversial)

Page 143: Slackers Guide  to Hematologic Cancers

• What are the screening tools for prostate cancer

Page 144: Slackers Guide  to Hematologic Cancers

• Digital rectal exam• PSA

Page 145: Slackers Guide  to Hematologic Cancers

• What is the staging for prostate cancer

Page 146: Slackers Guide  to Hematologic Cancers

• T1 – incidental finding• T2 – confined to prostate• T3 – outside of prostate capsule• T4 – Invading other pelvic structures

Page 147: Slackers Guide  to Hematologic Cancers

• Which patients should receive radiation therapy

Page 148: Slackers Guide  to Hematologic Cancers

Low riskT1-T2a

Radiation or radical prostatectomy

Medium riskT2b/c, PSA 10-20

Radiation if expected survival > 10 yearsHormone therapy

High riskT3, PSA > 20

RadiationHormone therapy

Page 149: Slackers Guide  to Hematologic Cancers

• Define initiation

Page 150: Slackers Guide  to Hematologic Cancers

• A mutation defect resulting in a phenotypically normal but altered cell.

Page 151: Slackers Guide  to Hematologic Cancers

• Define promotion

Page 152: Slackers Guide  to Hematologic Cancers

• The proliferation of a cell as a result of genetic changes occurring in initiation

Page 153: Slackers Guide  to Hematologic Cancers

• Define progression

Page 154: Slackers Guide  to Hematologic Cancers

• Acquisition of additional mutations in an initiated/promoted cell that confer more advanced neoplastic phenotype

Page 155: Slackers Guide  to Hematologic Cancers

• Describe tumorgenesis in skin cancer

Page 156: Slackers Guide  to Hematologic Cancers

• Cells are initiated by uv or other environmental insults. Over time promotion and progression occur until a frank tumor arises.

Page 157: Slackers Guide  to Hematologic Cancers

• What is the prevalence of basal cell carcinoma, squamous cell carcinoma, and malignant melanoma.

Page 158: Slackers Guide  to Hematologic Cancers

• BCC– #1 epithelial skin cancer– Low death rates

• Squamous cell carcinoma– #2 epithelial skin cancer– Low death rates

• Malignant melanoma– #3 skin cancer (?)– #1 in deaths (75%)

Page 159: Slackers Guide  to Hematologic Cancers

• Describe basal cell carcinoma

Page 160: Slackers Guide  to Hematologic Cancers

• Slow growing epithelial skin cancer with no known precursor lesion that is locally invasive and only rarely metastatic.

• Often translucent when stretched due to mucin (?)

Page 161: Slackers Guide  to Hematologic Cancers

• Where do BCC’s arise

Page 162: Slackers Guide  to Hematologic Cancers

• Keratinocytes associated with hair follicles

Page 163: Slackers Guide  to Hematologic Cancers

• What is the role of ptch1 in bcc

Page 164: Slackers Guide  to Hematologic Cancers

• Patch -----| smo ------> n-myc

• N-myc is a proliferative gene

Page 165: Slackers Guide  to Hematologic Cancers

• Describe grolin’s syndrome

Page 166: Slackers Guide  to Hematologic Cancers

• An inheritable defect in ptch1 that predisposes carriers to BCC

Page 167: Slackers Guide  to Hematologic Cancers

• What is the precursor lesion of squamous cell carcinoma

Page 168: Slackers Guide  to Hematologic Cancers

• Actinic keratosis

Page 169: Slackers Guide  to Hematologic Cancers

• Describe AK

Page 170: Slackers Guide  to Hematologic Cancers

• A rough, dry, scaly, red/brown patch on the skin.

Page 171: Slackers Guide  to Hematologic Cancers

• Describe the role of the immune system in SCC development

Page 172: Slackers Guide  to Hematologic Cancers

• The immune systems role is not well described but it plays some role as SCC increases with immune suppression and stimulation of the adaptive system is a treatment for both SCC and BCC.

Page 173: Slackers Guide  to Hematologic Cancers

• What are common genetic defects seen in SCC

Page 174: Slackers Guide  to Hematologic Cancers

• INK4a – a tumor suppressor is inactivated• P53 \/• Map kinase /\• NF-kB /\

Page 175: Slackers Guide  to Hematologic Cancers

• What is xeroderma pigmentosum

Page 176: Slackers Guide  to Hematologic Cancers

• A germline mutation in genes involved in nucleotide excision repair.

• Associated with increased levels of BCC and SCC

Page 177: Slackers Guide  to Hematologic Cancers

• Why is XP associated but not causative for BCC/SCC

Page 178: Slackers Guide  to Hematologic Cancers

• Uv is a major culprit in creating dimers that must be removed by excision repair. Therefore, if an XP patient were to limit their sunlight exposure, they limit their risk of developing SCC and BCC

Page 179: Slackers Guide  to Hematologic Cancers

• Why is malignant melanoma prone to metastasis?

Page 180: Slackers Guide  to Hematologic Cancers

• Melanoma arises from melanocytes which are of neural crest origin. These cells migrate widely in the developing embryo and its believed that this trait is re-emerges in cancer.

Page 181: Slackers Guide  to Hematologic Cancers

• What are the ABCD’s

Page 182: Slackers Guide  to Hematologic Cancers

• A tribute band to AC/DC– http://www.abcdband.com/

• Melanoma mnemonic – Asymmetry - asymmetrical– Borders - irregular– Color - uneven– Diameter - 6mm+

Page 183: Slackers Guide  to Hematologic Cancers

• What are the two phases of melanoma development and their prognosis

Page 184: Slackers Guide  to Hematologic Cancers

• Radial phase– Growth contained to the plane of the epidermis. – Curable with surgery alone

• Vertical phase– Growth perpendicular to the plane of the

epidermis resulting in invasion of the dermis and underlying tissue

Page 185: Slackers Guide  to Hematologic Cancers

• Explain the role of melanoma depth of invasion as a prognostic indicator

Page 186: Slackers Guide  to Hematologic Cancers

• Depth of invasion is inversely related to prognosis. In other words, deeper = deadlier.

Page 187: Slackers Guide  to Hematologic Cancers

• What is the role of growth factors in malanomagenesis

Page 188: Slackers Guide  to Hematologic Cancers

• Melanoma cells eventually gain self sufficiency in growth signals by producing their own fibroblast growth factor, a substance normally generated by keratinocytes.

Page 189: Slackers Guide  to Hematologic Cancers

• Once again, what is INK4

Page 190: Slackers Guide  to Hematologic Cancers

• A gene located on CR9 that is lost in 20-40% of melanomas. Hereditary melanomas are associated with loss of INK4A.

• A negative regulation of cell growth through the RB pathways

Page 191: Slackers Guide  to Hematologic Cancers

• What is the CDKN2A locus

Page 192: Slackers Guide  to Hematologic Cancers

• A critical locus on CR9 in that codes for INK4a and p14ARF. Both genes act as negative regulators of cell growth pathways.

Page 193: Slackers Guide  to Hematologic Cancers

• For no reason at all here’s Abu

Page 194: Slackers Guide  to Hematologic Cancers
Page 195: Slackers Guide  to Hematologic Cancers

• List the types of ultraviolet light

Page 196: Slackers Guide  to Hematologic Cancers

• UVA– Mildly carcinogenic– Photoaging

• Solar elastosis?

• UVB– Carcinogenic– Causes burns

• UVC– Highly carcinogenic– Blocked by ozone

Page 197: Slackers Guide  to Hematologic Cancers

• Are sunscreens protective for sundamage

Page 198: Slackers Guide  to Hematologic Cancers

• Sort of. SPF relates the amount of UVB blocked by a properly applied sunscreen. There is no current rating for blocking UVA and many sunscreens do not do so.

• Many people use sunscreens to extend the time they are in the sun thus effectively negating their benefit.

Page 199: Slackers Guide  to Hematologic Cancers

• What is the best therapy for malignant melanoma

Page 200: Slackers Guide  to Hematologic Cancers

• Early detection combined with excision.• Non-surgical interventions have poor

performance

• Proper prior planning prevents painfully poor performance.

Page 201: Slackers Guide  to Hematologic Cancers

• Make up your own sentence where every word begins with P.

Page 202: Slackers Guide  to Hematologic Cancers

• Perfectly posed purple plumed piccolo players piped prodigiously

• Pink penguins played peek-a-boo

Page 203: Slackers Guide  to Hematologic Cancers

• What are the histological hallmarks of melanoma

Page 204: Slackers Guide  to Hematologic Cancers

• Lack of maturation with descent• Single cells predominate over nests • Pagetoid appearance with migration upward

resulting in buckshot appearance

Page 205: Slackers Guide  to Hematologic Cancers

• Where would you typically expect to see superficial spreading malignant melanoma and what phase is it in

Page 206: Slackers Guide  to Hematologic Cancers

• On intermittently sunburned skin• Radial phase

Page 207: Slackers Guide  to Hematologic Cancers

• Where would you expect to see lentigo melanoma and what phase is it in

Page 208: Slackers Guide  to Hematologic Cancers

• On chronically sun damaged skin in the elderly• Radial phase

Page 209: Slackers Guide  to Hematologic Cancers

• What phase is nodular melanoma in

Page 210: Slackers Guide  to Hematologic Cancers

• Vertical• Can be rapidly fatal

Page 211: Slackers Guide  to Hematologic Cancers

• Where would you expect to find acral lentiginous melanoma and what phase is it in

Page 212: Slackers Guide  to Hematologic Cancers

• On darker skinned people on the palms, soles, and nails. Radial phase.

Page 213: Slackers Guide  to Hematologic Cancers

• What are the poor histologic factors for melanoma

Page 214: Slackers Guide  to Hematologic Cancers

• Thickness– > 1mm

• Ulceration• Vascular invasion• Microscopic satellites• Increased mitotic rate• Minimal lymphoid response• Partial regression


Recommended